gland pharma glp-1 manufacturing india India's pharmaceutical industry is witnessing another massive strategic move ππ Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a βΉ1,369 crore deal, signaling stronger expansion, integrated gland pharma glp-1 manufacturing india
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 29 - Sep 3


)













![Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases](https://static.elsevier.es/multimedia/00017310/0000011500000001/v1_202401030514/S0001731023008505/v1_202401030514/en/main.assets/fx1.jpeg)






